Birch C - Search Results

1

Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.

Tachedjian G, Mellors J, Bazmi H, Birch C, Mills J. Tachedjian G, et al. Among authors: birch c. J Virol. 1996 Oct;70(10):7171-81. doi: 10.1128/JVI.70.10.7171-7181.1996. J Virol. 1996. PMID: 8794364 Free PMC article.

2

Long-term foscarnet therapy not associated with the development of foscarnet-resistant human immunodeficiency virus type 1 in an acquired immunodeficiency syndrome patient.

Tachedjian G, Hoy J, McGavin K, Birch C. Tachedjian G, et al. Among authors: birch c. J Med Virol. 1994 Feb;42(2):207-11. doi: 10.1002/jmv.1890420220. J Med Virol. 1994. PMID: 7512615

3

Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1.

Tachedjian G, Hooker DJ, Gurusinghe AD, Bazmi H, Deacon NJ, Mellors J, Birch C, Mills J. Tachedjian G, et al. Among authors: birch c. Virology. 1995 Sep 10;212(1):58-68. doi: 10.1006/viro.1995.1453. Virology. 1995. PMID: 7545854 Free article.

4

Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.

Gurusinghe AD, Land SA, Birch C, McGavin C, Hooker DJ, Tachedjian G, Doherty R, Deacon NJ. Gurusinghe AD, et al. Among authors: birch c. J Med Virol. 1995 Jul;46(3):238-43. doi: 10.1002/jmv.1890460312. J Med Virol. 1995. PMID: 7561796

5

An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.

Hooker DJ, Tachedjian G, Solomon AE, Gurusinghe AD, Land S, Birch C, Anderson JL, Roy BM, Arnold E, Deacon NJ. Hooker DJ, et al. Among authors: birch c. J Virol. 1996 Nov;70(11):8010-8. doi: 10.1128/JVI.70.11.8010-8018.1996. J Virol. 1996. PMID: 8892925 Free PMC article.

6

Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.

Birch CJ, Tyssen DP, Tachedjian G, Doherty R, Hayes K, Mijch A, Lucas CR. Birch CJ, et al. J Infect Dis. 1992 Jul;166(1):108-12. doi: 10.1093/infdis/166.1.108. J Infect Dis. 1992. PMID: 1318909

7

Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.

Birch CJ, Tachedjian G, Doherty RR, Hayes K, Gust ID. Birch CJ, et al. J Infect Dis. 1990 Sep;162(3):731-4. doi: 10.1093/infdis/162.3.731. J Infect Dis. 1990. PMID: 2167340

8

In vitro effectiveness of a combination of zidovudine and ansamycin against human immunodeficiency virus.

Birch C, Tachedjian G, Lucas CR, Gust I. Birch C, et al. J Infect Dis. 1988 Oct;158(4):895. doi: 10.1093/infdis/158.4.895. J Infect Dis. 1988. PMID: 3171233 No abstract available.

9

Cellular topoisomerase I activity associated with HIV-1.

Jardine D, Tachedjian G, Locarnini S, Birch C. Jardine D, et al. Among authors: birch c. AIDS Res Hum Retroviruses. 1993 Dec;9(12):1245-50. doi: 10.1089/aid.1993.9.1245. AIDS Res Hum Retroviruses. 1993. PMID: 8142141

10

Diethanolamine fusidate has no in-vitro activity against the human immunodeficiency virus.

Birch C, Tachedjian G, Gust I. Birch C, et al. Med J Aust. 1988 Aug 15;149(4):224-5. doi: 10.5694/j.1326-5377.1988.tb120581.x. Med J Aust. 1988. PMID: 3173182 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page